Goldman Sachs Maintains Sell on Elanco Animal Health, Raises Price Target to $12.5
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Nathan Rich has maintained a Sell rating on Elanco Animal Health (NYSE:ELAN) but increased the price target from $10 to $12.5.

January 17, 2024 | 3:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Goldman Sachs reaffirmed a Sell rating on Elanco Animal Health but raised the price target to $12.5, indicating a potential downside from the current price level.
The reaffirmation of a Sell rating by a major analyst like Goldman Sachs typically exerts downward pressure on a stock's price. However, the increase in the price target may slightly mitigate the negative impact as it suggests a less bearish outlook than before. The mixed signal could lead to short-term volatility as the market digests the news.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100